282 related articles for article (PubMed ID: 30115681)
21. MyD88 oligomer size functions as a physical threshold to trigger IL1R Myddosome signaling.
Deliz-Aguirre R; Cao F; Gerpott FHU; Auevechanichkul N; Chupanova M; Mun Y; Ziska E; Taylor MJ
J Cell Biol; 2021 Jul; 220(7):. PubMed ID: 33956941
[TBL] [Abstract][Full Text] [Related]
22. Association of Polymorphisms in IRAK1, IRAK4 and MyD88, and Severe Invasive Pneumococcal Disease.
Carrasco-Colom J; Jordan I; Alsina L; Garcia-Garcia JJ; Cambra-Lasaosa FJ; Martín-Mateos MA; Juan M; Muñoz-Almagro C
Pediatr Infect Dis J; 2015 Sep; 34(9):1008-13. PubMed ID: 26075815
[TBL] [Abstract][Full Text] [Related]
23. IRAK4 turns IL-10+ phospho-FOXO+ monocytes into pro-inflammatory cells by suppression of protein kinase B.
Over B; Ziegler S; Foermer S; Weber AN; Bode KA; Heeg K; Bekeredjian-Ding I
Eur J Immunol; 2013 Jun; 43(6):1630-42. PubMed ID: 23519847
[TBL] [Abstract][Full Text] [Related]
24. A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4.
Alsina L; Israelsson E; Altman MC; Dang KK; Ghandil P; Israel L; von Bernuth H; Baldwin N; Qin H; Jin Z; Banchereau R; Anguiano E; Ionan A; Abel L; Puel A; Picard C; Pascual V; Casanova JL; Chaussabel D
Nat Immunol; 2014 Dec; 15(12):1134-42. PubMed ID: 25344726
[TBL] [Abstract][Full Text] [Related]
25. A noncanonical IRAK4-IRAK1 pathway counters DNA damage-induced apoptosis independently of TLR/IL-1R signaling.
Li Y; Shah RB; Sarti S; Belcher AL; Lee BJ; Gorbatenko A; Nemati F; Yu H; Stanley Z; Rahman M; Shao Z; Silva JM; Zha S; Sidi S
Sci Signal; 2023 Dec; 16(816):eadh3449. PubMed ID: 38113335
[TBL] [Abstract][Full Text] [Related]
26. Identification of the protein kinases that activate the E3 ubiquitin ligase Pellino 1 in the innate immune system.
Goh ET; Arthur JS; Cheung PC; Akira S; Toth R; Cohen P
Biochem J; 2012 Jan; 441(1):339-46. PubMed ID: 22007846
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.
Abend JR; Ramalingam D; Kieffer-Kwon P; Uldrick TS; Yarchoan R; Ziegelbauer JM
J Virol; 2012 Nov; 86(21):11663-74. PubMed ID: 22896623
[TBL] [Abstract][Full Text] [Related]
28. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.
Béla SR; Dutra MS; Mui E; Montpetit A; Oliveira FS; Oliveira SC; Arantes RM; Antonelli LR; McLeod R; Gazzinelli RT
Infect Immun; 2012 Dec; 80(12):4298-308. PubMed ID: 23027530
[TBL] [Abstract][Full Text] [Related]
29. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.
Kim TW; Staschke K; Bulek K; Yao J; Peters K; Oh KH; Vandenburg Y; Xiao H; Qian W; Hamilton T; Min B; Sen G; Gilmour R; Li X
J Exp Med; 2007 May; 204(5):1025-36. PubMed ID: 17470642
[TBL] [Abstract][Full Text] [Related]
30. Systematic analysis of immunodeficiency.
Tough DF
Nat Immunol; 2014 Dec; 15(12):1097-8. PubMed ID: 25396343
[TBL] [Abstract][Full Text] [Related]
31. Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor-associated kinase 4 (IRAK4).
Wang L; Ferrao R; Li Q; Hatcher JM; Choi HG; Buhrlage SJ; Gray NS; Wu H
J Biol Chem; 2019 Mar; 294(12):4511-4519. PubMed ID: 30679311
[TBL] [Abstract][Full Text] [Related]
32. Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML.
Bennett J; Ishikawa C; Agarwal P; Yeung J; Sampson A; Uible E; Vick E; Bolanos LC; Hueneman K; Wunderlich M; Kolt A; Choi K; Volk A; Greis KD; Rosenbaum J; Hoyt SB; Thomas CJ; Starczynowski DT
Blood; 2023 Sep; 142(11):989-1007. PubMed ID: 37172199
[TBL] [Abstract][Full Text] [Related]
33. IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness.
Qin J; Jiang Z; Qian Y; Casanova JL; Li X
J Biol Chem; 2004 Jun; 279(25):26748-53. PubMed ID: 15084582
[TBL] [Abstract][Full Text] [Related]
34. Identification and functional characterization of three myeloid differentiation factor 88 (MyD88) isoforms from thick shell mussel Mytilus coruscus.
Guo B; Liu S; Li J; Liao Z; Liu H; Xia H; Qi P
Fish Shellfish Immunol; 2018 Dec; 83():123-133. PubMed ID: 30205204
[TBL] [Abstract][Full Text] [Related]
35. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
36. Mmm-derived lipid-associated membrane proteins activate IL-1β production through the NF-κB pathway via TLR2, MyD88, and IRAK4.
Wang Y; Wang Q; Li Y; Chen Y; Shao J; Nick N; Li C; Xin J
Sci Rep; 2017 Jun; 7(1):4349. PubMed ID: 28659605
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of Imidazo[1,2-b]pyridazine IRAK4 inhibitors for the treatment of mutant MYD88 L265P diffuse large B-cell lymphoma.
Chen Y; Bai G; Ning Y; Cai S; Zhang T; Song P; Zhou J; Duan W; Ding J; Xie H; Zhang H
Eur J Med Chem; 2020 Mar; 190():112092. PubMed ID: 32014679
[TBL] [Abstract][Full Text] [Related]
38. IRAK4 as a molecular target in the amelioration of innate immunity-related endotoxic shock and acute liver injury by chlorogenic acid.
Park SH; Baek SI; Yun J; Lee S; Yoon DY; Jung JK; Jung SH; Hwang BY; Hong JT; Han SB; Kim Y
J Immunol; 2015 Feb; 194(3):1122-30. PubMed ID: 25548221
[TBL] [Abstract][Full Text] [Related]
39. IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease.
Staschke KA; Dong S; Saha J; Zhao J; Brooks NA; Hepburn DL; Xia J; Gulen MF; Kang Z; Altuntas CZ; Tuohy VK; Gilmour R; Li X; Na S
J Immunol; 2009 Jul; 183(1):568-77. PubMed ID: 19542468
[TBL] [Abstract][Full Text] [Related]
40. Expression of high mobility group B1 and toll-like receptor-nuclear factor κB signaling pathway in chronic subdural hematomas.
Osuka K; Watanabe Y; Usuda N; Iwami K; Miyachi S; Takayasu M
PLoS One; 2020; 15(6):e0233643. PubMed ID: 32479555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
